We identify and share funding opportunities as they arise to help advance MPT research and development. The items below are listed from the earliest to latest application due dates. We encourage you to browse below and contact us if you hear of any new opportunities.


Social and Behavior Change Research Award


USAID is seeking to strengthen the generation and utilization of evidence on social and behavior change programming that addresses agency of individuals and communities to improve the uptake and continuation of healthy behaviors, including family planning and reproductive health (FP/RH), maternal and child health (MCH), nutrition, and/or other outcomes. This includes socio-behavioral research around desirability and acceptability of MPT products.

Additional details can be found at USAID Business Forecast Search and searching within “Title/Description/A&A Plan ID” for Award Opportunity: AA-312481, then hit enter.

  • A&A Plan ID: AA-312481
  • Anticipated Release Date: 26 February 2021
  • Letters of Intent Due: TBD
  • Application Due: TBD

Biological Testing Facility (X01 Clinical Trial Not Allowed)


The Eunice Kennedy Shriver National Institute of Child Health and Human Development’s (NICHD) state-of-the art Biological Testing Facility supports female and/or male non-hormonal contraception development, including MPTs. This opportunity is to support the enablement of an IND/IDE study of a pre-clinical candidate that offers a safe, non-hormonal based therapy for female and/or male contraception that acts prior to fertilization and does not act via the hypothalamic-pituitary-gonadal axis. Additional details can be found at www.GRANTS.gov by searching within “Search Grants” for Funding Opportunity Number: PAR-21-078, then clicking on the opportunity number.

  • Funding Opportunity #: PAR-21-078
  • Open Date: 15 December 2020
  • Letters of Intent Due: Not Applicable
  • Application Due: 15 July 2021, 14 January 2022, 15 July 2022

User-Based Design to Aid in Contraceptive Development by Small Business (R43 Clinical Trial Not Allowed)

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites SBIR applications to study and identify characteristics that inform acceptability, desirability, and excitement of potential end-users of novel contraceptive products currently in the development pipeline for both men and women, including MPTs. Additional details for this Funding Opportunity Announcement (FOA) can be found here.

  • Funding Opportunity #: RFA-HD-22-019
  • Open Date: 29 June 2021
  • Letter of Intent Due Date(s): 30 days prior to application receipt date
  • Application Due: 29 July 2021

Contraception Development Research Center Program (P50 Clinical Trial Optional)


The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is seeking to support and facilitate multidisciplinary approaches towards the development of new and/or improved contraceptive methods for women and men through the formation of a Contraceptive Research Development Center. The NICHD is accepting applications including translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success and sociobehavioral and market research to test user acceptability for contraceptive products being developed. The Center will also serve as a national resource for development of early-stage investigators electing to pursue careers in contraceptive research. Applications focused on the late-stage pre-clinical development or clinical development of a single non-hormonal MPT with both contraceptive and anti-infective properties are of high priority. Additional details can be found at www.GRANTS.gov by searching within “Search Grants” for Funding Opportunity Number: RFA-HD-22-003, then clicking on the opportunity number.

  • Funding Opportunity #: RFA-HD-22-003
  • Open Date: 28 February 2021
  • Letters of Intent Due: 29 October 2021
  • Application Due: 29 November 2021

Family Planning and Reproductive Health Methods APS


The United States Agency for International Development (USAID) is seeking to support the research, development, and introduction of technologies and approaches that better meet the needs of women as their sexual and reproductive health concerns change over time. This includes the development of multipurpose prevention technologies (MPTs) that address the simultaneous risks of unintended pregnancy, HIV, and other sexually transmitted infections (STIs)—particularly Herpes Simplex Virus (HSV) and Human Papillomavirus (HPV). Additional details can be found on the Round 4 call for concept papers at www.GRANTS.gov by searching within “Search Grants” for Funding Opportunity Number: SOL-OAA-13-000024, then clicking on the opportunity number.

  • Funding Opportunity #: SOL-OAA-13-000024
  • Open Date: 15 January 2013
  • Concept Papers Due: 14 February 2020
  • Application Due: 14 January 2023

Comprehensive Resources for HIV Microbicides and Biomedical Prevention (CRMP)

This contract provides gap-filling support services for HIV prevention drug developers including academic (investigators), for-profit and not-for-profit small and large companies, and other product innovators (henceforth identified as Sponsors) for the development of HIV non-vaccine biomedical prevention (nBP) strategies and products. The types of nBPs supported include, but are not limited to, topical microbicides, pre-exposure prophylaxis (PrEP) and Multipurpose Prevention Technologies (MPT’s) for the purpose of preventing HIV transmission and acquisition in adolescents, women, men and transgender individuals. Sponsors seeking these services receive no funding from NIAID, but instead receive products or information generated by NIAID-funded contractors on their behalf. Data and reports are provided in a format that supports a regulatory filing. Additional details can be found here.

  • Who can use this resource?
    • Sponsors must have a defined need or gap that is delaying or blocking further advancement of their product to clinical testing and/or licensure.
    • Sponsors need preliminary data and/or regulatory agency input supporting a justification for the requested support.
    • If in support of a specific grant activity, the Sponsor needs to demonstrate a critical need to the advancement of the grant objectives that cannot be met by rebudgeting or administrative supplement, if applicable.  
  • How to get started: Follow the procedures for requesting access to NIAID contract services
  • Application Due: Rolling basis